|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Clinical management potential tumours of low malignancy显示文摘 | Gershenson DM | 2002 | Best Pract Res Clin Obstet Gynaecol2002，16，4： | 1 |
| 2 | Managementof early ovarian cancer: germ cell and sex cord-stromal tumors 显示文摘 | Gershenson DM | 1994 | Gynecol Oncol1994，55，32： | 1 |
| 3 | Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer显示文摘 | Jacob JH Gershenson DM Morris M | 1991 | Gynecol Oncol1991，42，2： | 1 |
| 4 | Treatment of poorprognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin 显示文摘 | Gershenson DM Morris M Burke TW | 1996 | Obstet Gynocol1996，87，2： | 1 |
| 5 | The current status of surgical staging of ovarian serous borderline tumor 显示文摘 | Lin PS Gershenson DM Bevels MW | 1999 | Cancer1999，85，4： | 1 |
| 6 | Expression of cell-cycle mediators in ovarian cancer cells after transfection with P16( INK4a), P21 ( WAF1/Cip-1 ), and P53 显示文摘 | Ramirez PT Gershenson DM Tortolero Luna G | 2001 | Gynecol Oncol2001，83，3： | 1 |
| 7 | Treatment of poorpr-ognosis sexcord-stomal tumors of ovary with the combination of bleomycin,etopside and cisplatin显示文摘 | Gershenson DM Morris M Burke TW | 1996 | Obstet Gynecol1996，87，4： | 1 |
| 8 | Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a),p21(WAF1/Cip-1),and p53显示文摘 | Gershenson DM Tortolero-Luna G | 2001 | Gynecol Oncol2001，83，： | 1 |
| 9 | Paclitax- el and cisplatin as first-line therapy in recurrent or ad- vanced squamous cell carcinoma of the cervix: a gyne- cologic oncology group study显示文摘 | Rose PG Blessing JA Gershenson DM | 1999 | J Clin Oncol1999，17，9： | 1 |
| 10 | Chronic stress promotes tumor growth and angiogenesis in a mouse model of i cinoma 显示文摘 | Gershenson DM Kundra V Lopez-Berestein G | 2006 | Nat Med2006，12，8： | 1 |
| 11 | Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum显示文摘 | Gershenson DM Sun CC Iyer RB | 2012 | Gynecol Oncol2012，125，： | 1 |
| 12 | Postoperative adjuvant cisplatin,doxorubicin,and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma显示文摘 | Burke TW Gershenson DM Morris M | 1994 | Gynecol Oncol1994，55，： | 1 |
| 13 | Outcome and reproductive function after conservative surgery for borderline ovarian tumors显示文摘 | Morise RT Gershenson Dm Silva EG | 2000 | Obstet Gynecol2000，95，4： | 1 |
| 14 | Intraoperative lymphatic mapping for vulvar cancer 显示文摘 | Levenback C Burke TW Gershenson DM | 1994 | Obstet Gynecol1994，84，2： | 1 |
| 15 | Irinotecan in epithelial ovarian cancer显示文摘 | Gershenson DM | 2002 | Oncology(Huntingt)2002，16，55： | 1 |
| 16 | Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer显示文摘 | Jacob JH Gershenson DM Morris M | 1991 | Gynecol Oncol1991，42，： | 1 |
| 17 | Salvage sur- gery for chemorefractory ovarian germ cell tumors显示文摘 | Munkarah A Gershenson DM Levenback C | 1994 | Gynecol Oncol1994，55，： | 1 |
| 18 | Postoperative adjuvant cisplatin,doxorubicin,and cyclophosphamide(PAC)chemotherapy in women with high-risk endometrial carcinoma显示文摘 | Burke TW Gershenson DM Morris M | 1994 | Gynecol Oncol1994，55，1： | 1 |
| 19 | Sexual dysfunction and treatment for early stage cervical cancer 显示文摘 | Schover LR Fife M Gershenson DM | 1989 | Cancer1989，63，1： | 1 |
| 20 | Outcome and re- productive {unction after conservative surgery for borderline o- varian tumors显示文摘 | Morris RT Gershenson DM Silva EG | 2000 | Obstet Gyneco2000，95，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员